Cours Body and Mind Inc. Other OTC
Actions
BMMJ
US09689V1008
Produits pharmaceutiques
CA 2022 | 31,64 M 28,62 M | CA 2023 | 22,82 M 20,64 M | Capitalisation | 11,88 M 10,74 M |
---|---|---|---|---|---|
Résultat net 2022 | -28 M -25,33 M | Résultat net 2023 | -20 M -18,09 M | VE / CA 2022 | 0,73 x |
Dette nette 2022 | 11,67 M 10,56 M | Dette nette 2023 | 18,38 M 16,63 M | VE / CA 2023 | 1,33 x |
PER 2022 |
-0,39
x | PER 2023 |
-0,52
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 86,53% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Mills
CEO | Chief Executive Officer | 55 | 12/06/18 |
Dong Shim
DFI | Director of Finance/CFO | 40 | 15/12/16 |
Chief Operating Officer | 59 | 15/11/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Joshua Rosen
BRD | Director/Board Member | 51 | 01/02/23 |
Brent Reuter
BRD | Director/Board Member | 56 | 16/10/19 |
Michael Mills
CEO | Chief Executive Officer | 55 | 12/06/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+39,33% | 6,11 Md | |
-18,38% | 4,35 Md | |
-9,17% | 3,19 Md | |
+3,98% | 3,15 Md | |
-3,41% | 2,51 Md | |
+48,74% | 1,98 Md | |
-4,82% | 1,74 Md | |
-1,24% | 1,63 Md | |
-8,96% | 1,6 Md |